KPTI logo

KPTI

Karyopharm Therapeutics Inc.

$7.11
-$0.57(-7.42%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$64.69M
Volume
132.50K
52W Range
$3.51 - $16.95
Target Price
$15.92
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$250.0K$154.0K$1.6M$30.3M$40.9M$108.1M$209.8M$157.1M$146.0M$145.2M
Total Revenue
$250.0K$154.0K$1.6M$30.3M$40.9M$108.1M$209.8M$157.1M$146.0M$145.2M
COST OF GOODS SOLD
Cost of Revenue
----------$2.7M$3.4M$5.2M----
GROSS PROFIT
Gross Profit
$250.0K$154.0K$1.6M$30.3M$40.9M$105.4M$206.4M$151.9M$146.0M$145.2M
OPERATING EXPENSES
Operating Expenses
$-119.3M$-110.9M$-132.1M$210.2M$230.2M$279.9M$308.1M$294.1M$275.6M$264.7M
Research & Development
$97.7M$86.9M$107.3M$161.4M$122.3M$150.8M$160.8M$148.7M$138.8M$143.2M
Research Expense
$97.7M$86.9M$107.3M$161.4M$122.3M$150.8M$160.8M$148.7M$138.8M$143.2M
Selling, General & Administrative
$21.6M$23.9M$24.9M$48.8M$105.4M$126.4M$143.8M$145.4M$131.9M$115.4M
Selling & Marketing Expenses
------$48.8M$105.4M$126.4M--------
General & Administrative Expenses
$21.6M$23.9M$24.9M$48.8M$105.4M$126.4M$143.8M$145.4M$131.9M$115.4M
Salaries & Wages
$-17.1M$-22.3M$-20.4M$-17.3M$2.4M$2.7M$29.8M$35.4M$21.7M$18.4M
Depreciation & Amortization
$-634.0K$-717.0K$-713.0K$-700.0K$1.0M$1.0M$789.0K$621.0K----
Depreciation & Amortization
$-634.0K$-717.0K$-713.0K$-700.0K$-1.0M$1.0M$789.0K$621.0K----
Other Operating Expenses
$-119.3M$-110.9M$-132.1M$-210.2M$2.4M$2.7M$2.8M$2.8M$2.8M$2.8M
OPERATING INCOME
Operating income
$-119.1M$-110.7M$-130.5M$-179.9M$-189.3M$-171.8M$-98.3M$-142.2M$-129.5M$-119.4M
EBITDA
$-115.8M$-107.5M$-127.0M$-173.7M$-177.1M$-167.9M$-94.6M$-139.3M$-141.4M$-32.2M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
------$2.5M$15.6M$27.1M$26.0M$25.0M$23.8M$37.4M
Intinc
$897.0K$1.3M$1.7M$4.0M$5.4M$2.8M$582.0K$2.4M$10.9M$7.4M
Net Non-Operating Interest Income/Expense
$897.0K$1.3M$1.7M$1.5M$-10.2M$-24.3M$-25.5M$-22.6M$10.9M$7.4M
Gain on Sale of Securities
----------$500.0K$90.0K------
Other Income/Expense
$2.0K$-10.0K$81.0K$33.0K$50.0K$-206.0K$85.0K$-83.0K$356.0K$-73.1M
Other Special Charges
$-2.0K$10.0K$-81.0K$-33.0K$-50.0K$206.0K$-85.0K$-83.0K$-356.0K$73.1M
PRE-TAX INCOME
EBIT
$-118.2M$-109.4M$-128.9M$-175.9M$-183.9M$-168.8M$-97.8M$-139.9M$-142.8M$-38.9M
Pre-Tax Income
$-118.2M$-109.4M$-128.9M$-178.4M$-199.6M$-196.0M$-123.8M$-164.9M$-142.8M$-76.4M
INCOME TAX
Tax Provision
--$139.0K$63.0K$26.0K$40.0K$309.0K$268.0K$369.0K$323.0K$57.0K
NET INCOME
Net Income
$-118.2M$-109.6M$-129.0M$-178.4M$-199.6M$-196.3M$-124.1M$-165.3M$-143.1M$-76.4M
Net Income (Continuing Operations)
$-118.2M$-109.6M$-129.0M$-178.4M$-199.6M$-196.3M$-124.1M$-165.3M$-143.1M$-76.4M
Net Income (Discontinued Operations)
$-118.2M$-109.6M$-129.0M$-178.4M$-199.6M$-196.3M$-124.1M$-165.3M$-143.1M$-76.4M
Net Income (Common Stockholders)
$-118.2M$-109.6M$-129.0M$-178.4M$-199.6M$-196.3M$-124.1M$-165.3M$-143.1M$-76.4M
TOTALS
Total Expenses
$-119.3M$-110.9M$-132.1M$210.2M$230.2M$279.6M$311.5M$299.3M$275.6M$264.7M
SHARE & EPS DATA
Average Shares Outstanding
$2.4M$2.5M$3.1M$3.8M$4.1M$4.8K$5.0M$81.9M$7.6M$121.9K
Average Shares Outstanding (Diluted)
$2.4M$2.5M$3.1M$3.8M$4.1M$4.8K$5.0M$81.9M$7.6M$126.8K
Shares Outstanding
$2.4M$2.8M$3.3M$4.1M$4.4M$5.0M$5.3M$113.3M$7.7M$126.2M
Basic EPS
--------$-3.22$-2.72$-24.75$-2.02$-18.75$-0.63
Basic EPS (Continuing Operations)
------------$-24.75$-2.02$-18.75$-0.63
Diluted EPS
$-49.8$-43.8$-42.15$-47.1$-48.3$-40.8$-24.75$-2.02$-18.75$-0.93
Diluted EPS (Continuing Operations)
------$-47.1$-48.3$-40.8--$-2.02$-18.75$-0.93
OTHER METRICS
Other Gand A
$21.6M$23.9M$24.9M$48.8M$105.4M$126.4M$143.8M$145.4M$131.9M$115.4M
Rent And Landing Fees
$21.6M$23.9M$24.9M$-2.5M------------
Selling Expense
------$48.8M$105.4M$126.4M--------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2KPTI$7.11-7.4%132.50K
3
4
5
6

Get Karyopharm Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.